Article
Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response
25 Oct 2020
Abstract excerpt
Cancer will directly affect the lives of over one-third of the population. The DNA Damage Response (DDR) is an intricate system involving damage recognition, cell cycle regulation, DNA repair, and ultimately cell fate determination, playing a central role in cancer etiology and therapy. Two primary therapeutic approaches involving DDR targeting include: combinatorial treatments employing anticancer genotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
